GSK plc (GSK) Q2 2024 Earnings Call Transcript - Seeking Alpha

GSK Plc (GSK) Q2 2024 Earnings Call Transcript - Seeking Alpha

1 week from now

Jul 31, 2024  · Play Call. EPS of $1.11 beats by $0.13 | Revenue of $10.13B (9.04% Y/Y) beats by $501.97M. GSK plc (NYSE: GSK) Q2 2024 Earnings Conference Call July 31, 2024 7:00 AM …

seekingalpha.com

Q2 2024 Results Conference Call And Webcast For Investors And …

1 week from now

Slide 5 | H1 2024 momentum drives upgraded guidance I am delighted to report that GSK’s momentum this year continues with excellent second-quarter performance. Sales grew 13% to …

gsk.com

GSK: Earnings Confirm It's On Track To Meet Guidance

1 week from now

Oct 30, 2024  · Summary. GSK is on track to achieve its guidance for 2024, with its Q3 2024 and 9m 2024 results today. For 9m 2024, the company's turnover growth at 9% is at the upper end …

seekingalpha.com

Second Quarter 2024 - GSK

1 week from now

GSK delivers continued strong performance and upgrades 2024 guidance Broad-based performance drives sales, core profit and core EPS growth: • Total Q2 2024 sales £7.9 billion …

gsk.com

GSK Q3 Earnings Preview: Shingrix & Arexvy Make The ... - Seeking …

1 week from now

Oct 26, 2024  · A year ago, GSK’s EBIT margins were 24.3%, and as of Q2 2024, they reached 16.5%. This massive margin decline could become GSK’s main drawback unless …

seekingalpha.com

GSK Beats Q2 Earnings & Sales Estimates, Ups 2024 Guidance

1 week from now

Jul 31, 2024  · Written by Zacks Equity Research for Zacks ->. GSK plc GSK reported core earnings of $1.09 per American depositary share (ADS) in second-quarter 2024, beating the …

nasdaq.com

GSK On Track To Deliver 2024 Outlooks With Further Good Progress …

1 week from now

Oct 30, 2024  · Q3 2024 sales and core earnings growth driven by strong performance of Specialty Medicines helping to offset lower Vaccines sales: Vaccines sales -15%. Shingrix -7% and …

gsk.com

Third Quarter 2024 - GSK

1 week from now

If exchange rates were to hold at the closing rates on 30 September 2024 ($1.34/£1, €1.20/£1 and Yen 191/£1) for the rest of 2024, the estimated impact on 2024 Sterling turnover growth …

gsk.com

GSK Q2 2024 Earnings Preview - MSN

1 week from now

GSK (NYSE:GSK) is scheduled to announce Q2 earnings results on Wednesday, July 31st, before market open. The consensus EPS Estimate is $0.98 (-97.5% Y/Y) and the consensus …

msn.com

GSK Raises Forecasts For 2024, But Shares Slide | Pharmaphorum

1 week from now

5 days ago  · GSK raises forecasts for 2024, but shares slide. GSK posted a healthy 13% increase in second-quarter sales this morning and raised its forecasts for the year on the back of gains …

pharmaphorum.com